Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis

References

• Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of C-Fms and receptor activator of nuclear factor κb (Rank) receptors. J Exp Med. 1999;190(12):1741–10. doi:10.1084/jem.190.12.1741.
   PubMed Web of Science ®Google Scholar
• Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13(18):2412–2424. doi:10.1101/gad.13.18.2412.
   PubMed Web of Science ®Google Scholar
• Buckle CH, De Leenheer E, Lawson MA, Yong K, Rabin N, Perry M, et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. PLoS One. 2012;7(8):e41127.
   PubMed Web of Science ®Google Scholar
• Moreaux J, Legouffe E, Jourdan E, Quittet P, Rème T, Lugagne C, et al. BAFF and April protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood. 2004;103(8):3148–3157.
   PubMed Web of Science ®Google Scholar
• Abe M, Hiura K, Wilde J, Shioyasono A, Moriyama K, Hashimoto T, et al. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood. 2004;104(8):2484–2491.
   PubMed Web of Science ®Google Scholar
• Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004;428(6984):758–763.
   PubMed Web of Science ®Google Scholar
• Mócsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A,Spusta SC, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004;101(16):6158–6163.
   PubMed Web of Science ®Google Scholar
• MacLellan LM, Montgomery J, Sugiyama F, Kitson SM, Thummler K, Silverman GJ, et al. Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice. Arthritis Rheum. 2011;63(12):3897–3907.
   PubMedGoogle Scholar
• Grevers LC, de Vries TJ, Everts V, Verbeek JS, van den Berg WB, van Lent PL. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcgamma receptors on myeloid precursor cells. Ann Rheum Dis. 2013;72(2):278–285.
   PubMed Web of Science ®Google Scholar
• Harre U, Keppeler H, Ipseiz N, Derer A, Poller K, Aigner M, Schett G, Herrmann M, Lauber K. Moonlighting osteoclasts as undertakers of apoptotic cells. Autoimmunity. 2012;45(8):612–619. doi:10.3109/08916934.2012.719950.
   PubMed Web of Science ®Google Scholar
• Negishi-Koga T, Gober HJ, Sumiya E, Komatsu N, Okamoto K,Sawa S, et al. Immune complexes regulate bone metabolism through FcRγ signalling. Nat Commun. 2015;6:6637.
   PubMed Web of Science ®Google Scholar
• Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, et al. Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A. 2013;110(26):10729–10734.
   PubMed Web of Science ®Google Scholar
• Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012;122(5):1791–1802.
   PubMed Web of Science ®Google Scholar
• Harre U, Lang SC, Pfeifle R, Rombouts Y, Frühbeißer S, Amara K, et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun. 2015;6:6651.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Lim E, Mun S, Bae S, Murata K, Ivashkiv B, et al. Intravenous immunoglobulin (IVIG) attenuates TNF-induced pathologic bone resorption and suppresses osteoclastogenesis by inducing A20 expression. J Cell Physiol. 2016;231(2):449–458.
   PubMed Web of Science ®Google Scholar
• Yaccoby S, Wezeman MJ, Henderson A, Cottler-Fox M, Yi Q, Barlogie B, et al. Cancer and the microenvironment: myeloma-osteoclast interactions as a model. Cancer Res. 2004;64(6):2016–2023.
   PubMed Web of Science ®Google Scholar
• Cole JJ, Faydaci BA, McGuinness D, Shaw R, Maciewicz RA,Robertson NA, et al. Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts. BMC Bioinform. 2021;22(1):411.
   PubMed Web of Science ®Google Scholar
• Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett. 2007;110(1):54–64.
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365–386.
   PubMedGoogle Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Carini C, Hunter E, Ramadass AS, Green J, Akoulitchev A,McInnes IB, et al. Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis. J Transl Med. 2018;16(1):18.
   PubMedGoogle Scholar
• Toubal A, Clément K, Fan R, Ancel P, Pelloux V, Rouault C, et al. SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation. J Clin Invest. 2013;123(1):362–379.
   PubMed Web of Science ®Google Scholar
• Cui Q, Shibata H, Oda A, Amou H, Nakano A, Yata K, et al. Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells. Int J Hematol. 2011;94(1):63–70.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–686.
   PubMed Web of Science ®Google Scholar
• Sims NA, Quinn JM. Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease. Bonekey Rep. 2014;3:527.
   PubMedGoogle Scholar
• Jay PR, Centrella M, Lorenzo J, Bruce AG, Horowitz MC. Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption. Endocrinology. 1996;137(4):1151–1158.
   PubMed Web of Science ®Google Scholar
• Walker EC, McGregor NE, Poulton IJ, Solano M, Pompolo S,Fernandes TJ, et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest. 2010;120(2):582–592.
   PubMed Web of Science ®Google Scholar
• Nicolaidou V, Wong MM, Redpath AN, Ersek A, Baban DF,Williams LM, et al. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One. 2012;7(7):e39871.
   PubMed Web of Science ®Google Scholar
• Walker EC, Johnson RW, Hu Y, Brennan HJ, Poulton IJ, Zhang JG, et al. Murine oncostatin M Acts via leukemia inhibitory factor receptor to phosphorylate signal transducer and activator of transcription 3 (STAT3) but not STAT1, an effect that protects bone mass. J Biol Chem. 2016;291(41):21703–21716.
   PubMed Web of Science ®Google Scholar
• Duplomb L, Baud'huin M, Charrier C, Berreur M, Trichet V,Blanchard F, et al. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine 727 phosphorylation of signal transducer and activator of transcription 3. Endocrinology. 2008;149(7):3688–3697.
   PubMed Web of Science ®Google Scholar
• Ling JQ, Hoffman AR. Epigenetics of long-range chromatin interactions. Pediatr Res. 2007;61:11r–16r.
   PubMed Web of Science ®Google Scholar
• Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science. 2002;295(5558):1306–1311.
   PubMed Web of Science ®Google Scholar
• Vahedi G, Kanno Y, Furumoto Y, Jiang K, Parker SC,Erdos MR, et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature. 2015;520(7548):558–562.
   PubMed Web of Science ®Google Scholar
• Osato N. Discovery of biased orientations of regulatory motifs affecting transcription of human genes and including known insulators. bioRxiv. 2020;290825. doi:10.1101/290825.
   Google Scholar
• Osato N. Characteristics of functional enrichment and gene expression level of human putative transcriptional target genes. BMC Genomics. 2018;19:957.
   PubMed Web of Science ®Google Scholar
• Mourad R, Li L, Cuvier O. Uncovering direct and indirect molecular determinants of chromatin loops using a computational integrative approach. PLoS Comput Biol. 2017;13:e1005538.
   PubMed Web of Science ®Google Scholar